Alumis (ALMS) Total Liabilities (2023 - 2025)
Alumis (ALMS) reported Total Liabilities of $110.6 million for Q4 2025, up 36.79% year-over-year from $80.9 million in Q4 2024, and up 7.17% quarter-over-quarter from $103.2 million in Q3 2025.
Alumis (ALMS) Total Liabilities (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Total Liabilities data on file, last reported at $110.6 million in Q4 2025.
- Total Liabilities for Q4 2025 came in at $110.6 million, up 36.79% year-over-year; the trailing twelve-month figure through Dec 2025 was $110.6 million (up 36.79% YoY), and the FY2025 annual result was $110.6 million, up 36.79% from the prior year.
- Total Liabilities climbed to $110.6 million in Q4 2025 per ALMS's latest filing, from $103.2 million in the prior quarter.
- Over five years, Total Liabilities peaked at $385.9 million in Q1 2024 and troughed at $53.5 million in Q4 2023.
- A 3-year average of $149.7 million and a median of $103.2 million in 2025 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities slumped 78.83% in 2024, then soared 94.13% in 2025.
- A 3-year view of Total Liabilities shows it stood at $53.5 million in 2023, then soared by 51.19% to $80.9 million in 2024, then soared by 36.79% to $110.6 million in 2025.
- Business Quant data shows ALMS's Total Liabilities at $110.6 million in Q4 2025, $103.2 million in Q3 2025, and $125.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | 110.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 110.64 Mn |
| Sep 30, 2025 | 103.24 Mn |
| Jun 30, 2025 | 125.60 Mn |
| Mar 31, 2025 | 92.98 Mn |
| Dec 31, 2024 | 80.89 Mn |
| Sep 30, 2024 | 64.17 Mn |
| Jun 30, 2024 | 64.70 Mn |
| Mar 31, 2024 | 385.93 Mn |
| Dec 31, 2023 | 53.50 Mn |
| Sep 30, 2023 | 303.07 Mn |
| Jun 30, 2023 | 262.35 Mn |